Biomarkers of micro-inflammation, such as C-reactive protein (CRP), serve as predictive tools for the development and monitoring of the acute coronary syndrome, as inflammation is considered a target that can be therapeutically improved [3, 13]. The gene discussed is CRP; the disease is acute coronary syndrome.